MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0175762

Медицинская библиотека · PloS one · 2017

Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.

Kang Yu Mi, Jung Chang Hee, Cho Yun Kyung, Lee Seung Eun, Lee Min Jung, Hwang Jenie Yoonoo, Kim Eun Hee, Park Joong-Yeol, Lee Woo Je, Kim Hong-Kyu

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression.

METHODS

We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by ≥2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m2) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography.

RESULTS

Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93-2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34-4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71-2.24).

CONCLUSIONS

Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status.

Для цитирования: Kang Yu Mi, Jung Chang Hee, Cho Yun Kyung, Lee Seung Eun, Lee Min Jung, Hwang Jenie Yoonoo, Kim Eun Hee, Park Joong-Yeol, Lee Woo Je, Kim Hong-Kyu. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.. PloS one. 2017. DOI: 10.1371/journal.pone.0175762.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.